At a glance
ClinicalIndex Comparison RecordN/ACompleted· 398 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IV, Multi-Centric, Prospective, Observational Study to Assess the Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis
In Brief
An observational study for Active Rheumatoid Arthritis. Completed, enrolled 398 participants across 1 site.
Detailed Summary
A Phase IV, Multi-Centric, Prospective, Observational Study to Assess the Clinical Efficacy and Safety of Leflunomide in Egyptian Patients with Active Rheumatoid Arthritis. (CLEAR)
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsActive Rheumatoid Arthritis
CountriesEgypt
CollaboratorsDataClin
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJun 2017
First PostedJul 2018
Primary CompletionOct 2018
TodayJul 2026
First PostedJul 26, 2018
Enrollment StartJun 16, 2017
Primary CompletionOct 13, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.9 years ago